甘油三酯-葡萄糖指数与骨健康相关性研究进展

doi:10.3877/cma.j.issn.2095-655X.2026.02.011

骨质疏松症(OP)是一种慢性代谢性骨病，随着全球人口老龄化的加剧，其发病率不断上升，为全球公共卫生带来了巨大的负担。胰岛素抵抗(IR)作为全身代谢异常的关键环节，介导的骨重塑稳态失衡及骨质量受损，是驱动OP发生发展的核心病理生理基础。甘油三酯-葡萄糖(TyG)指数作为IR的便捷替代指标，在评估骨健康的应用中日益广泛，但其与骨密度、骨转换标志物及骨折风险的关联尚存在争议。因此，笔者探讨TyG指数与骨健康之间的关系，旨在为临床实践中OP的风险评估与早期干预提供新的视角。

关键词: 甘油三酯-葡萄糖指数, 胰岛素抵抗, 骨质疏松, 骨密度, 脆性骨折

Osteoporosis(OP)is a chronic metabolic bone disease that has become increasingly prevalent due to the global aging population, imposing a significant burden on public health worldwide. Insulin resistance(IR), a major systemic metabolic abnormality, disrupts bone remodeling homeostasis and impairs bone quality, serving as a key pathophysiological mechanism for the onset and progression of OP. The triglyceride-glucose(TyG) index, an convenient alternative marker for IR, is increasingly utilized to evaluate bone health; however, its association with bone mineral density, bone turnover markers, and fracture risk remains controversial. Therefore, this review elucidates the relationship between the TyG index and bone health, aiming to provide a new perspective for risk assessment and early intervention of OP in clinical practice.

Key words: Triglyceride-glucose index, Insulin resistance, Osteoporosis, Bone density, Fragility fracture

[1]	Salcido Reyna MV，Bazán PL，Yurac Barrientos R，et al.Bone health in the 21st century：biology，function，and resilience for a "Universal Clinical Definition" '.SILACO Research Group[J].Cirugía de Columna，2026，4(1)：33-40.DOI：10.35366/121956.
[2]	NIH consensus development panel on osteoporosis prevention，diagnosis，therapy.Osteoporosis prevention，diagnosis，and therapy[J].JAMA，2001，285(6)：785-795.DOI：10.1001/jama.285.6.785.
[3]	Peng Y，Zhong Z，Huang C，et al.The effects of popular diets on bone health in the past decade：a narrative review[J].Front Endocrinol (Lausanne)，2024(14)：1287140.DOI：10.3389/fendo.2023.1287140.
[4]	Cosman F, de Beur SJ, LeBoff MS, et al. Clinician′s guide to prevention and treatment of osteoporosis[J].Osteoporos Int，2014，25(10)：2359-2381.DOI：10.1007/s00198-014-2794-2.
[5]	Kenkre JS，Bassett J．The bone remodelling cycle[J].Ann Clin Biochem，2018，55(3)：308-327.DOI：10.1177/0004563218759371.
[6]	Anam AK, Insogna K. Update on osteoporosis screening and management[J].Med Clin North Am，2021，105(6)：1117-1134.DOI：10.1016/j.mcna.2021.05.016.
[7]	Kushchayeva Y，Pestun I，Kushchayev S，et al.Advancement in the treatment of osteoporosis and the effects on bone healing[J].J Clin Med，2022，11(24)：7477.DOI：10.3390/jcm11247477.
[8]	Naso CM，Lin SY，Song G，et al.Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA，2005-2018[J].Osteoporos Int，2025，36(3)：547-554.DOI：10.1007/s00198-025-07395-3.
[9]	Kanis JA，Johnell O，Oden A，et al.Long-term risk of osteoporotic fracture in Malmö[J].Osteoporos Int，2000，11(8)：669-674.DOI：10.1007/s001980070064.
[10]	Curtis EM，van der Velde R，Moon RJ，et al.Epidemiology of fractures in the United Kingdom 1988-2012：variation with age，sex，geography，ethnicity and socioeconomic status[J].Bone，2016(87)：19-26.DOI：10.1016/j.bone.2016.03.006.
[11]	Biamonte E，Bendotti G，Nigro G，et al.Bone health in metabolic syndrome-is it a neglected aspect of dysmetabolic-related diseases？[J].J Clin Med，2025，14(16).DOI：10.3390/jcm14165785.
[12]	Shi W，Zhang Q．Association between metabolic syndrome and the musculoskeletal system[J].Nutrients，2023，15(20)：4475.DOI：10.3390/nu15204475.
[13]	Yaribeygi H, Farrokhi FR, Butler AE, et al. Insulin resistance：review of the underlying molecular mechanisms[J].J Cell Physiol，2019，234(6)：8152-8161.DOI：10.1002/jcp.27603.
[14]	Napoli N，Conte C，Pedone C，et al.Effect of insulin resistance on BMD and fracture risk in older adults[J].J Clin Endocrinol Metab，2019，104(8)：3303-3310.DOI：10.1210/jc.2018-02539.
[15]	Armutcu F, McCloskey E. Insulin resistance, bone health, and fracture risk[J].Osteoporos Int，2024，35(11)：1909-1917.DOI：10.1007/s00198-024-07227-w.
[16]	Moriyama K．Mini-review on insulin resistance assessment：advances in surrogate indices and clinical applications[J].World J Clin Cases，2025，13(29)：108380.DOI：10.12998/wjcc.v13.i29.108380.
[17]	Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance：focusing on the role of HOMA-IR and tryglyceride/glucose index[J].Diabetes Metab Syndr，2022，16(8)：102581.DOI：10.1016/j.dsx.2022.102581.
[18]	Placzkowska S，Pawlik-Sobecka L，Kokot I，et al.Indirect insulin resistance detection：current clinical trends and laboratory limitations[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub，2019，163(3)：187-199.DOI：10.5507/bp.2019.021.
[19]	Simental-Mendía LE，Rodríguez-Morán M，Guerrero-Romero F．The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects[J].Metab Syndr Relat Disord，2008，6(4)：299-304.DOI：10.1089/met.2008.0034.
[20]	Guerrero-Romero F，Simental-Mendía LE，González-Ortiz M，et al.The product of triglycerides and glucose，a simple measure of insulin sensitivity.Comparison with the euglycemic-hyperinsulinemic clamp[J].J Clin Endocrinol Metab，2010，95(7)：3347-3351.DOI：10.1210/jc.2010-0288.
[21]	Li C，Zhang Z，Luo X，et al.The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients：insights from NHANES data with machine learning analysis[J].Cardiovasc Diabetol，2025，24(1)：47.DOI：10.1186/s12933-025-02591-1.
[22]	Chen Q, Hu P, Hou X, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease[J].Cardiovasc Diabetol，2024，23(1)：232.DOI：10.1186/s12933-024-02343-7.
[23]	Huang X，Ye J，Liu S，et al.Association of triglyceride-glucose body mass index with target organ damage in essential hypertension：a retrospective cohort study[J].J Clin Hypertens (Greenwich)，2025，27(8)：e70114.DOI：10.1111/jch.70114.
[24]	雍家成，朱菲，陈昊，等．自然人群甘油三酯葡萄糖指数与骨质疏松关系的横断面研究[J].实用临床医药杂志，2023，27(6)：29-32，38.DOI：10.7619/jcmp.20230223.
[25]	Lai T，Su Z，Chen R，et al.The association between different insulin resistance indexes and bone health in the elderly[J].PLoS One，2025，20(2)：e0318356.DOI：10.1371/journal.pone.0318356.
[26]	陈静，方红丽，刘绒．围绝经期女性甘油三酯葡萄糖指数和肥胖相关复合指标与骨量异常的相关性研究[J].微循环学杂志，2025，35(3)：91-95.DOI：10.3969/j.issn.1005-1740.2025.03.016.
[27]	Xu J，Yu L，Liu F，et al.The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis：a review[J].Front Immunol，2023(14)：1222129.DOI：10.3389/fimmu.2023.1222129.
[28]	Ferron M，Wei J，Yoshizawa T，et al.Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism[J].Cell，2010，142(2)：296-308.DOI：10.1016/j.cell.2010.06.003.
[29]	Yang J, Zhang X, Wang W, et al. Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells[J].Cell Biochem Funct，2010，28(4)：334-341.DOI：10.1002/cbf.1668.
[30]	Luo M，Zhao Z，Yi J．Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia[J].Front Endocrinol (Lausanne)，2023(14)：1150068.DOI：10.3389/fendo.2023.1150068.
[31]	Hussein N，Meade JL，Pandit H，et al.The effect of diabetes mellitus on IGF axis and stem cell mediated regeneration of the periodontium[J].Bioengineering (Basel)，2021，8(12).DOI：10.3390/bioengineering8120202.
[32]	Wong SK，Mohamad NV，Jayusman PA，et al.A review on the crosstalk between insulin and wnt/β-catenin signalling for bone health[J].Int J Mol Sci，2023，24(15).DOI：10.3390/ijms241512441.
[33]	Shoelson SE，Lee J，Goldfine AB.Inflammation and insulin resistance[J].J Clin Invest，2006，116(7)：1793-1801.DOI：10.1172/JCI29069.
[34]	Dobre MZ，Virgolici B，Timnea O．Key roles of brown，subcutaneous，and visceral adipose tissues in obesity and insulin resistance[J].Curr Issues Mol Biol，2025，47(5)：343.DOI：10.3390/cimb47050343.
[35]	Varra FN，Varras M，Varra VK，et al.Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation-mediating treatment options (review)[J].Mol Med Rep，2024，29(6)：95.DOI：10.3892/mmr.2024.13219.
[36]	Ootsuka T，Nakanishi A，Tsukamoto I．Increase in osteoclastogenesis in an obese Otsuka Long-Evans Tokushima fatty rat model[J].Mol Med Rep，2015，12(3)：3874-3880.DOI：10.3892/mmr.2015.3811.
[37]	Peric Kacarevic Z，Snajder D，Maric A，et al.High-fat diet induced changes in lumbar vertebra of the male rat offsprings[J].Acta Histochem，2016，118(7)：711-721.DOI：10.1016/j.acthis.2016.08.002.
[38]	Okamoto K，Nakashima T，Shinohara M，et al.Osteoimmunology：the conceptual framework unifying the immune and skeletal systems[J].Physiol Rev，2017，97(4)：1295-1349.DOI：10.1152/physrev.00036.2016.
[39]	Tian K，Xiong T，Zeng D，et al.Impact of reactive oxygen species on bone regeneration in diabetes：mechanisms and therapeutic strategies[J].Redox Biol，2025(88)：103941.DOI：10.1016/j.redox.2025.103941.
[40]	Wang YB，Li ZP，Wang P，et al.Iron dysregulation，ferroptosis，and oxidative stress in diabetic osteoporosis：mechanisms，bone metabolism disruption，and therapeutic strategies[J].World J Diabetes，2025，16(6)：106720.DOI：10.4239/wjd.v16.i6.106720.
[41]	Sharma P，Sharma RK，Gaur K．Understanding the impact of diabetes on bone health：a clinical review[J].Metabol Open，2024(24)：100330.DOI：10.1016/j.metop.2024.100330.
[42]	Jia X, Zhang G, Yu D. Application of extracellular vesicles in diabetic osteoporosis[J].Front Endocrinol (Lausanne)，2024(15)：1466775.DOI：10.3389/fendo.2024.1466775.
[43]	Wang B，Vashishth D．Advanced glycation and glycoxidation end products in bone[J].Bone，2023(176)：116880.DOI：10.1016/j.bone.2023.116880.
[44]	Paula FJ，Rosen CJ.Obesity，diabetes mellitus and last but not least，osteoporosis[J].Arq Bras Endocrinol Metabol，2010，54(2)：150-157.DOI：10.1590/s0004-27302010000200010.
[45]	Mohsin S，Baniyas MM，AlDarmaki RS，et al.An update on therapies for the treatment of diabetes-induced osteoporosis[J].Expert Opin Biol Ther，2019，19(9)：937-948.DOI：10.1080/14712598.2019.1618266.
[46]	Wang J，Cui W．Decoding the diabetic bone paradox：how AGEs sabotage skeletal integrity[J].Cell Rep Med，2024，5(9)：101693.DOI：10.1016/j.xcrm.2024.101693.
[47]	Ferrari S，Akesson KE，Al-Daghri N，et al.Bone microstructure and TBS in diabetes：what have we learned? A narrative review[J].Osteoporos Int，2025，36(7)：1115-1128.DOI：10.1007/s00198-025-07495-0.
[48]	Mikolajewicz N，Bishop N，Burghardt AJ，et al.HR-pQCT measures of bone microarchitecture predict fracture：systematic review and meta-analysis[J].J Bone Miner Res，2020，35(3)：446-459.DOI：10.1002/jbmr.3901.
[49]	Atria PJ，Castillo AB.Skeletal adaptation to mechanical cues during homeostasis and repair：the niche，cells，and molecular signaling[J].Front Physiol，2023(14)：1233920.DOI：10.3389/fphys.2023.1233920.
[50]	Wang B，Liu J，Wang Q，et al.Piezo1 activation suppresses bone marrow adipogenesis to prevent osteoporosis by inhibiting a mechanoinflammatory autocrine loop[J].Signal Transduct Target Ther，2025，10(1)：357.DOI：10.1038/s41392-025-02455-w.
[51]	Li Y，Luo Y，Huang D，et al.Sclerostin as a new target of diabetes-induced osteoporosis[J].Front Endocrinol (Lausanne)，2024(15)：1491066.DOI：10.3389/fendo.2024.1491066.
[52]	俞海燕，郭晓珍，黄文龙，等.2型糖尿病患者FRAX评分及骨密度与BMI的相关性分析[J].中国骨质疏松杂志，2017，23(6)：761-763，767.DOI：10.3969/j.issn.1006-7108.2017.06.012.
[53]	Shahen VA，Gerbaix M，Koeppenkastrop S，et al.Multifactorial effects of hyperglycaemia，hyperinsulinemia and inflammation on bone remodelling in type 2 diabetes mellitus[J].Cytokine Growth Factor Rev，2020(55)：109-118.DOI：10.1016/j.cytogfr.2020.04.001.
[54]	徐露璐，盛志峰，杨燕贻，等．绝经后女性和50岁及以上男性甘油三酯葡萄糖指数与骨密度的关系：一项横断面研究[J].健康体检与管理，2024，5(2)：106-112.
[55]	Nakamura T，Imai Y，Matsumoto T，et al.Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts[J].Cell，2007，130(5)：811-823.DOI：10.1016/j.cell.2007.07.025.
[56]	Vilaca T，Eastell R，Schini M．Osteoporosis in men[J].Lancet Diabetes Endocrinol，2022，10(4)：273-283.DOI：10.1016/S2213-8587(22)00012-2.
[57]	Aguirre LE，Colleluori G，Fowler KE，et al.High aromatase activity in hypogonadal men is associated with higher spine bone mineral density，increased truncal fat and reduced lean mass[J].Eur J Endocrinol，2015，173(2)：167-174.DOI：10.1530/EJE-14-1103.
[58]	Yan Y, Wang L, Ge L, et al. Osteocyte-mediated translation of mechanical stimuli to cellular signaling and its role in bone and non-bone-related clinical complications[J].Curr Osteoporos Rep，2020，18(1)：67-80.DOI：10.1007/s11914-020-00564-9.
[59]	Yoon JH，Hong AR，Choi W，et al.Association of triglyceride-glucose index with bone mineral density in non-diabetic koreans：KNHANES 2008-2011[J].Calcif Tissue Int，2021，108(2)：176-187.DOI：10.1007/s00223-020-00761-9.
[60]	Caeran G，de Almeida LL，Ilha T，et al.Insulin resistance and its association with osteoporosis in people living with HIV[J].J Endocr Soc，2022，6(12)：bvac148.DOI：10.1210/jendso/bvac148.
[61]	Zhan J，Wei Q，Guo W，et al.Evaluating the triglyceride glucose index as a predictive biomarker for osteoporosis in patients with type 2 diabetes[J].Front Endocrinol (Lausanne)，2025(16)：1534232.DOI：10.3389/fendo.2025.1534232.
[62]	Korpe B, Kose C, Mermi S, et al. Investigating the triglyceride-glucose index in postmenopausal osteoporosis[J].Climacteric，2025，28(1)：81-86.DOI：10.1080/13697137.2024.2429430.
[63]	Zhan H, Liu X, Piao S, et al. Association between triglyceride-glucose index and bone mineral density in US adults：a cross sectional study[J].J Orthop Surg Res，2023，18(1)：810.DOI：10.1186/s13018-023-04275-6.
[64]	Zhuo M，Chen Z，Zhong ML，et al.Association of insulin resistance with bone mineral density in a nationwide health check-up population in China[J].Bone，2023(170)：116703.DOI：10.1016/j.bone.2023.116703.
[65]	吴雪．TyG、TG/HDL-c、LDL-c/HDL-c与绝经后2型糖尿病女性合并骨质疏松的相关性研究[D].宁夏医科大学，2025.DOI：10.27258/d.cnki.gnxyc.2025.000372.
[66]	Zhang J，Wang Y，Guo J，et al.The association between ten anthropometric measures and osteoporosis and osteopenia among postmenopausal women[J].Sci Rep，2025，15(1)：10994.DOI：10.1038/s41598-025-94218-4.
[67]	Wang X，Zhang C，Zhao G，et al.Obesity and lipid metabolism in the development of osteoporosis (review)[J].Int J Mol Med，2024，54(1)：61.DOI：10.3892/ijmm.2024.5385.
[68]	Tian N, Chen S, Han H, et al. Association between triglyceride glucose index and total bone mineral density：a cross-sectional study from NHANES 2011-2018[J].Sci Rep，2024，14(1)：4208.DOI：10.1038/s41598-024-54192-9.
[69]	陶倩．甘油三酯-葡萄糖指数结合肥胖相关指标与绝经后骨质疏松症的关系[D].合肥：安徽医科大学，2025.
[70]	郝金荣．TyG-BMI指数与新诊断2型糖尿病患者骨质疏松的相关性研究[D].延安：延安大学，2025.
[71]	Jia F，Lu Y，Wen H，et al.Correlations between TyG-related indices and bone health：a cross-sectional study of osteoporosis in a rural Chinese population[J].Diabetes Metab Syndr Obes，2025(18)：1445-1458.DOI：10.2147/DMSO.S505024.
[72]	Greenblatt MB，Tsai JN，Wein MN.Bone turnover markers in the diagnosis and monitoring of metabolic bone disease[J].Clin Chem，2017，63(2)：464-474.DOI：10.1373/clinchem.2016.259085.
[73]	孙文文.2型糖尿病患者甘油三酯葡萄糖体质量指数与骨转换标记物的相关性分析[D].唐山：华北理工大学，2025.
[74]	朱意佳．甘油三酯-葡萄糖指数及相关指数与2型糖尿病患者骨质疏松的相关性研究[D].南昌：南昌大学，2025.
[75]	刘则坤.2型糖尿病患者甘油三酯葡萄糖指数与骨质疏松及骨代谢标志物的相关性研究[D].太原：山西医科大学，2025.
[76]	Xu J，Guo SH，Xu MZ，et al.The association between the triglyceride-glucose index and bone turnover markers in osteoporotic fractures patients aged 50 and above who are hospitalized for surgical intervention：a retrospective cross-sectional study[J].Front Endocrinol (Lausanne)，2024(15)：1418271.DOI：10.3389/fendo.2024.1418271.
[77]	Seeman E，Delmas PD.Bone quality-the material and structural basis of bone strength and fragility[J].N Engl J Med，2006，354(21)：2250-2261.DOI：10.1056/NEJMra053077.
[78]	Nasser MI，Stidsen JV，Højlund K，et al.Low bone turnover associates with lower insulin sensitivity in newly diagnosed drug-naïve persons with type 2 diabetes[J].J Clin Endocrinol Metab，2023，108(7)：e371-e379.DOI：10.1210/clinem/dgad043.
[79]	Burr DB.Changes in bone matrix properties with aging[J].Bone，2019(120)：85-93.DOI：10.1016/j.bone.2018.10.010.
[80]	Turner CH.Bone strength：current concepts[J].Ann N Y Acad Sci，2006(1068)：429-446.DOI：10.1196/annals.1346.039.
[81]	de Waard E，Driessen J，de Jong J，et al.The association between insulin use and volumetric bone mineral density，bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes-the maastricht study[J].Bone，2017(101)：156-161.DOI：10.1016/j.bone.2017.05.004.
[82]	Lou Y，Chen H，Man F，et al.Association between the triglyceride-glucose index and fragility fractures among US adults：insights from NHANES[J].Diabetol Metab Syndr，2025，17(1)：96.DOI：10.1186/s13098-025-01669-w.
[83]	Pan J，Huang X，Wang Q，et al.Triglyceride glucose index is strongly associated with a fragility fracture in postmenopausal elderly females with type 2 diabetes mellitus combined with osteoporosis：a 6-year follow-up study[J].Clin Interv Aging，2023(18)：1841-1849.DOI：10.2147/CIA.S434194.

[1]	陈晓晓, 林成寿, 吴锦清, 缪娟, 刘成招, 刘清平, 王旭, 陈武桂. 闽东地区5 320例髋部骨折住院患者临床特征分析[J/OL]. 中华关节外科杂志(电子版), 2026, 20(02): 174-184.
[2]	董书恒, 孙庆, 屈一鸣. 椎体成形术联合抗骨质疏松药物治疗骨质疏松性椎体骨折[J/OL]. 中华关节外科杂志(电子版), 2025, 19(05): 586-596.
[3]	陈波波, 王冠乔, 王宏煜, 侯建业, 田野. 骨代谢指标与关节软骨损伤Outerbridge分级的相关性研究[J/OL]. 中华关节外科杂志(电子版), 2025, 19(04): 418-426.
[4]	卢帅, 陈建明, 李敏娟, 单祎宁, 曹仁巍, 查晔军, 蒋协远. 基于NHANES数据库分析抑郁与骨质疏松性骨折愈合不良的关联及预测模型构建与验证[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(03): 167-176.
[5]	石宛鑫, 商子梦, 吴桐, 卢帅, 邱倩, 徐艳利, 张强, 江宇泳, 刘秀颖, 蒋协远, 杨志云. 新型冠状病毒感染后中老年人维生素D缺乏对骨质疏松患病风险的影响[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(03): 136-145.
[6]	刘国路, 李乾, 王以金, 王苏贵, 胡好, 张璐. 甘油三酯-葡萄糖指数与肾细胞癌患者术后预后的关系[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 492-497.
[7]	田井梅, 袁玉霞, 李长桂, 龙舟, 杨聚豪, 汪涓. 肺-骨轴及其在COPD并发骨质疏松症中的机制研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 168-172.
[8]	余辉, 王双兰, 吴庆能, 杨昌其, 彭峰扬, 郭灯亮, 张艺, 崔丽, 吴佳佳. 血清骨保护素与慢性阻塞性肺疾病骨丢失和骨质疏松诊断的关系[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(04): 546-551.
[9]	张翠猛, 王玉, 王小影, 李大全, 郭敬然. 双能X线骨密度测定法与腰椎CT诊断在骨质疏松患者功能锻炼指导中的应用研究[J/OL]. 中华老年骨科与康复电子杂志, 2026, 12(02): 72-78.
[10]	曾凯, 樊仕才. 老年骨盆脆性骨折的治疗进展[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(06): 372-378.
[11]	李祖涛, 阿布都艾尼·热吾提, 车立新, 徐江波, 赵清斌. 应用生物信息学技术鉴定并验证绝经后骨质疏松症中靶点基因[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(04): 193-200.
[12]	沈二栋, 庄岩, 周凤金, 雷金来, 张堃. 骨盆机能不全骨折的诊治[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(04): 251-256.
[13]	王敬博, 宋伟福, 杨阳, 张云鸽, 李欣. 维生素D受体基因与老年骨质疏松关系[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(03): 186-192.
[14]	文丽君, 王渝洲, 蒋东波, 巫晓伟, 岳文胜. 超声脂肪分数对中青年代谢相关脂肪性肝病患者病情严重程度及糖脂代谢的评估价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(04): 370-375.
[15]	秦楠, 汪川, 穆尼热·穆合塔尔, 蒋升. 2 型糖尿病患者维生素D 与胰岛功能的相关性[J/OL]. 中华临床医师杂志(电子版), 2025, 19(03): 199-205.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Research progress on the correlation between triglyceride-glucose index and bone health

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Research progress on the correlation between triglyceride-glucose index and bone health